Parkinson's disease. What is the treatment of Parkinson's disease?
When treatment symptoms respond well to different period of time. This period is individual and depends on the form of the disease, tremors, rigid, rigid-bradikinetichna. Also by the treatment.
Treatment can be symptomatic or replacement by restoring the level of dopamine and stimulation of dopamine receptors.
Preventive treatment is aimed at preventing the progression of the disease. In Bulgaria adopted a consensus for the treatment of early Parkinson's disease. According to him delayed initiation of therapy with levodopa. In the early stages apply MAO-B inhibitors (Selegeline) or Amantadine, which have neuroprotective action. These medications are usually effective within the first 3-4 years of disease onset. Upon exhaustion of the clinical effect of switching to taking levodopa preparations.
Levodopa is a precursor of dopamine and thus complete deficiency of dopamine in the central nervous system. It works with dopa decarboxylase inhibitors, thus allowing for a reduced peripheral conversion of Levodopa in Dopamin. Dopamine agonists are chemicals that directly affect dopamine receptors striarnite. Apply for advanced Parkinson's disease with Levodopa. This drug is a drug Pramipexol. Anticholinesterase drugs (Akineton, Parkisan) have limited application in therapy because of their side effects. It is assumed that they affect mainly tremor. Modern treatment of Parkinson's disease include drug with neuroprotective effect on slowing the progression of disease and drug controlled release levodopa to ensure optimal levels of dopamine. In case of significant motor fluctuations associated with the assumption of a single dose of each drug is taken, the patient enters the late stage Parkinson's disease. Moreover, there are various complications caused by both the disease itself and from the medication.
Treatment of Parkinson's disease is mainly based on substitution of inadequate dopamine production by administration of levodopa (L-dopa) or by simulating effects of dopamine by administering DOPA agonists such as pramipexole, ropinirole, bromocriptine or pergolide. Levodopa is open as an option for treatment of Parkinson's disease Arvid Carlsson. Levodopa is a dopamine precursor, which undergoes transformation into dopamine in the brain structures. Preventive therapy aims to prevent disease progression by applying preparations neuroprotective effect.
No comments:
Post a Comment